Information Provided By:
Fly News Breaks for June 18, 2015
SUPN
Jun 18, 2015 | 06:43 EDT
Piper Jaffray raised its price target for Supernus Pharmaceuticals to $20 after the company's investor day yielded new pipeline information, specifically SPN-810 for impulsive aggression and SPN-812 for ADHD. Piper believes shares at current levels are not ascribing value to SPN-810 and SPN-812. It reiterates an Overweight rating on the stock.
News For SUPN From the Last 2 Days
There are no results for your query SUPN